Current and novel infusion therapies for patients with Parkinson's disease

Advanced Parkinson’s disease is characterized by periods of poor mobility, dyskinesia and progressive decline in functional independence of the affected person despite the manipulation of levodopa doses and the introduction of supplemental therapies such as catechol-O-methyl transferase inhibitors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonini, Angelo, D’Onofrio, Valentina, Guerra, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645652/
https://www.ncbi.nlm.nih.gov/pubmed/37672049
http://dx.doi.org/10.1007/s00702-023-02693-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645652/
https://www.ncbi.nlm.nih.gov/pubmed/37672049
http://dx.doi.org/10.1007/s00702-023-02693-8

Ejemplares similares